Lugano Financial Advisors SA (LFA)’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Lugano Financial Advisors SA (LFA)’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1K	Buy	+60	New	+$1.61K	﹤0.01%	158

Other funds holding FSTX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lugano Financial Advisors SA (LFA)'s FSTX Position: Q2 2019 in Review

Lugano Financial Advisors SA (LFA) opened a new position in F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019: 60 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #158 among its holdings.

50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

Lugano Financial Advisors SA (LFA) held 60 shares of F-star Therapeutics, Inc. Common Stock worth $1K as of Q2 2019.
F-star Therapeutics, Inc. Common Stock was a new Lugano Financial Advisors SA (LFA) position in Q2 2019.
F-star Therapeutics, Inc. Common Stock made up ﹤0.01% of Lugano Financial Advisors SA (LFA)'s portfolio in Q2 2019, its #158 holding.
50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q2 2019, filed 2 Aug 2019.